116 related articles for article (PubMed ID: 2906007)
1. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative.
MacDonald E; Scheinin H; Scheinin M
Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole.
MacDonald E; Haapalinna A; Virtanen R; Lammintausta R
Acta Vet Scand Suppl; 1989; 85():77-81. PubMed ID: 2571282
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
MacDonald E; Scheinin M; Scheinin H; Virtanen R
J Pharmacol Exp Ther; 1991 Nov; 259(2):848-54. PubMed ID: 1682487
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist.
Scheinin H; MacDonald E; Scheinin M
Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363
[TBL] [Abstract][Full Text] [Related]
6. Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.
Koulu M; Pesonen U; Koskinen S; Scheinin H; Virtanen R; Scheinin M
Pharmacol Toxicol; 1993 Mar; 72(3):182-7. PubMed ID: 8100065
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profiles of medetomidine and its antagonist, atipamezole.
Virtanen R
Acta Vet Scand Suppl; 1989; 85():29-37. PubMed ID: 2571275
[TBL] [Abstract][Full Text] [Related]
8. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
Pertovaara A; Kauppila T; Tukeva T
Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
[TBL] [Abstract][Full Text] [Related]
9. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
Rabin BC; Guo TZ; Gregg K; Maze M
Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
[TBL] [Abstract][Full Text] [Related]
10. Effect of sex and age on brain monoamines and spatial learning in rats.
Tanila H; Taira T; Piepponen TP; Honkanen A
Neurobiol Aging; 1994; 15(6):733-41. PubMed ID: 7891829
[TBL] [Abstract][Full Text] [Related]
11. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice.
Idänpään-Heikkilä JJ; Björn M; Seppälä T
Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679
[TBL] [Abstract][Full Text] [Related]
12. Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.
Vulliemoz Y; Shen H; Virag L
Anesthesiology; 1996 Sep; 85(3):544-50. PubMed ID: 8853084
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
14. Sedative effects of medetomidine and its reversal by atipamezole in llamas.
Waldridge BM; Lin HC; DeGraves FJ; Pugh DG
J Am Vet Med Assoc; 1997 Dec; 211(12):1562-5. PubMed ID: 9412685
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha 2-adrenergic drugs on the alcohol consumption of alcohol-preferring rats.
Korpi ER
Pharmacol Toxicol; 1990 Apr; 66(4):283-6. PubMed ID: 1973538
[TBL] [Abstract][Full Text] [Related]
16. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
[TBL] [Abstract][Full Text] [Related]
17. Reversal of medetomidine sedation in sheep by atipamezole and yohimbine.
Mohammad FK; Zangana IK; Abdul-Latif AR
Vet Hum Toxicol; 1995 Apr; 37(2):97-9. PubMed ID: 7631500
[TBL] [Abstract][Full Text] [Related]
18. Medetomidine--a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects.
Scheinin H; Virtanen R; MacDonald E; Lammintausta R; Scheinin M
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):635-51. PubMed ID: 2571177
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats.
Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of medetomidine sedation by atipamezole in pigs.
Nishimura R; Kim H; Matsunaga S; Sakaguchi M; Sasaki N; Tamura H; Takeuchi A
J Vet Med Sci; 1992 Dec; 54(6):1237-40. PubMed ID: 1362084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
